Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04722575
Title Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma (NEO-TIM)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fondazione Melanoma Onlus



Atezolizumab + Cobimetinib + Vemurafenib

Atezolizumab + Cobimetinib

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Ospedale S.M. Annunziata - Azienda USL Toscana Centro Not yet recruiting Bagno A Ripoli Firenze 50012 Italy Details
IRCCS - Istituto Scientifico Romagnolo per la Cura e lo Studio dei Tumori (I.R.S.T) S.r.l. Not yet recruiting Meldola Forlì-Cesena 47014 Italy Details
IRCCS San Martino - IST Recruiting Genova 16132 Italy Details
Fondazione I.R.C.C.S. Istituto Nazionale dei Tumori Not yet recruiting Milano 20133 Italy Details
Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale" Recruiting Naples 80131 Italy Details
Istituto Oncologico Veneto Recruiting Padova 35128 Italy Details
*Shaded cells indicate that there was no data available from for the field